Literature DB >> 11792832

Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE.

Franky Van Herreweghe1, Jianqiang Mao, Frank W R Chaplen, Johan Grooten, Kris Gevaert, Joël Vandekerckhove, Katia Vancompernolle.   

Abstract

Tumor necrosis factor (TNF)-induced cell death in the fibrosarcoma cell line L929 is a caspase-independent process that is characterized by increased production of reactive oxygen species (ROS) in the mitochondria. To elucidate this ROS-dependent cell death pathway, a comparative study of the phosphoproteins present in TNF-treated and control cells was performed. Here we report that TNF induces an increased phosphorylation of glyoxalase I that is mediated by protein kinase A and required for cell death. We also show that TNF induces a substantial increase in intracellular levels of methylglyoxal (MG) that leads to the formation of a specific MG-derived advanced glycation end product and that this formation occurs as a consequence of increased ROS production. These data indicate that MG modification of proteins is a targeted process and that MG may thus function as a signal molecule during the regulation of cell death. Furthermore, we provide evidence that the TNF-induced phosphorylation of glyoxalase I is not involved in detoxification of MG by means of the glyoxalase system, but that phosphorylated glyoxalase I is on the pathway leading to the formation of a specific MG-derived advanced glycation end product.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792832      PMCID: PMC117411          DOI: 10.1073/pnas.012432399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Peptide sequencing by matrix-assisted laser-desorption mass spectrometry.

Authors:  B Spengler; D Kirsch; R Kaufmann; E Jaeger
Journal:  Rapid Commun Mass Spectrom       Date:  1992-02       Impact factor: 2.419

2.  Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis.

Authors:  P J Thornalley; L G Edwards; Y Kang; C Wyatt; N Davies; M J Ladan; J Double
Journal:  Biochem Pharmacol       Date:  1996-05-17       Impact factor: 5.858

3.  Method for determination of free intracellular and extracellular methylglyoxal in animal cells grown in culture.

Authors:  F W Chaplen; W E Fahl; D C Cameron
Journal:  Anal Biochem       Date:  1996-07-01       Impact factor: 3.365

4.  Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity.

Authors:  J Grooten; V Goossens; B Vanhaesebroeck; W Fiers
Journal:  Cytokine       Date:  1993-11       Impact factor: 3.861

Review 5.  Advanced protein glycosylation in diabetes and aging.

Authors:  M Brownlee
Journal:  Annu Rev Med       Date:  1995       Impact factor: 13.739

Review 6.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

7.  Fluorimetric assay of D-lactate.

Authors:  A C McLellan; S A Phillips; P J Thornalley
Journal:  Anal Biochem       Date:  1992-10       Impact factor: 3.365

8.  Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins.

Authors:  M E Westwood; P J Thornalley
Journal:  J Protein Chem       Date:  1995-07

9.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity.

Authors:  V Goossens; J Grooten; K De Vos; W Fiers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin.

Authors:  T W Lo; M E Westwood; A C McLellan; T Selwood; P J Thornalley
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

View more
  25 in total

1.  Exploring post-translational arginine modification using chemically synthesized methylglyoxal hydroimidazolones.

Authors:  Tina Wang; Rendy Kartika; David A Spiegel
Journal:  J Am Chem Soc       Date:  2012-05-16       Impact factor: 15.419

2.  Phosphoproteomic identification of targets of the Arabidopsis sucrose nonfermenting-like kinase SnRK2.8 reveals a connection to metabolic processes.

Authors:  Ryoung Shin; Sophie Alvarez; Adrien Y Burch; Joseph M Jez; Daniel P Schachtman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

3.  Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism.

Authors:  Madhabi Barua; Edmund C Jenkins; Wenqiang Chen; Salomon Kuizon; Raju K Pullarkat; Mohammed A Junaid
Journal:  Autism Res       Date:  2011-04-12       Impact factor: 5.216

4.  Toxic concentrations of exogenously supplied methylglyoxal in hybridoma cell culture.

Authors:  Benjamin M Roy; Tiffany D Rau; R Robert Balcarcel
Journal:  Cytotechnology       Date:  2005-11-30       Impact factor: 2.058

5.  Cellular stress responses: cell survival and cell death.

Authors:  Simone Fulda; Adrienne M Gorman; Osamu Hori; Afshin Samali
Journal:  Int J Cell Biol       Date:  2010-02-21

6.  Tumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I.

Authors:  Virginie de Hemptinne; Dieter Rondas; Joël Vandekerckhove; Katia Vancompernolle
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

7.  Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor.

Authors:  Mohammed A Junaid; Dagmar Kowal; Madhabi Barua; Premila S Pullarkat; Susan Sklower Brooks; Raju K Pullarkat
Journal:  Am J Med Genet A       Date:  2004-11-15       Impact factor: 2.802

8.  Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation.

Authors:  Gerd Birkenmeier; Christin Stegemann; Ralf Hoffmann; Robert Günther; Klaus Huse; Claudia Birkemeyer
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

9.  Role for glyoxalase I in Alzheimer's disease.

Authors:  Feng Chen; M Axel Wollmer; Frederic Hoerndli; Gerald Münch; Björn Kuhla; Evgeny I Rogaev; Magdalini Tsolaki; Andreas Papassotiropoulos; Jürgen Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

10.  Arginine modifications by methylglyoxal: discovery in a recombinant monoclonal antibody and contribution to acidic species.

Authors:  Chris Chumsae; Kathreen Gifford; Wei Lian; Hongcheng Liu; Czeslaw H Radziejewski; Zhaohui Sunny Zhou
Journal:  Anal Chem       Date:  2013-11-18       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.